BETTA CARE INC. – Trademark Portfolio

Entity Type: 03

BETTA CARE INC. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 2 (Paints) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include CANBRY, AMOVIVA, and BETTACARE. The owner is based in CHINO, CA.

13875 RAMONA AVE

CHINO, CA 91710

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AMOVIVA
AMOVIVA
Registered 2025
BETTACARE
BETTACARE
Registered 2025
CANBRY
CANBRY
Registered 2022

Trademark Classifications

BETTA CARE INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

2
Paints (1 filing)

Paints, varnishes, lacquers; preservatives against rust and against deterioration of wood

Frequently Asked Questions

How many trademarks does BETTA CARE INC. have?

BETTA CARE INC. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does BETTA CARE INC. file in?

BETTA CARE INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 2 (Paints). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are BETTA CARE INC.'s most well-known trademarks?

BETTA CARE INC.'s registered trademark portfolio includes well-known marks such as CANBRY, AMOVIVA, and BETTACARE. These are among 3 currently registered trademarks in the portfolio.

What is BETTA CARE INC.'s trademark registration success rate?

BETTA CARE INC. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.